Yahoo Finance’s Adam Shapiro, Julie Hyman and Rick Newman, along with Interactive Brokers Chief Strategist Steve Sosnick and Sensus Healthcare CEO Joe Sardano discuss the different options to treat non-surgical cancer.
In 2010, Joe Sardano was appointed CEO of Sensus Healthcare, Inc. (NASDAQ:SRTS). This report will, first, examine the...
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, is pleased to announce it has shipped and installed a Sculptura™ radiation oncology system to Stanford Health Care in Palo Alto, Calif. The system was shipped in December. This is the third system to be shipped by Sensus and follows the sale of one system to Beilinson Hospital of the Rabin Medical Center in Israel and one to the University of Pennsylvania in Philadelphia.
BOCA RATON, Fla., May 07, 2020 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and.
Sensus Healthcare, Inc. (SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Wednesday, November 6, 2019 at 4:30 p.m. Eastern time to discuss the financial results for the third quarter ended September 30, 2019. To access the conference call, the dial-in numbers are 888-567-1603 (U.S. and Canada Toll Free), 862-298-0702 (International). Please direct the operator to be connected to the Sensus Healthcare conference call.
BOCA RATON, Fla., Nov. 21, 2019 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and.
Sensus Healthcare, Inc. (NASDAQ:SRTS) missed earnings with its latest quarterly results, disappointing...
Q1 2020 Sensus Healthcare Inc Earnings Call
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Fourth quarter net income up 10-fold to $1.0 million, diluted EPS of $0.06 Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 13, 2020 --.
Q4 2019 Sensus Healthcare Inc Earnings Call
Sensus Healthcare, Inc. (SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, May 7, 2020 at 4:30 p.m. Eastern time to discuss the financial results for the first quarter of 2020. To access the conference call, the dial-in numbers are 888-567-1603 (U.S. and Canada Toll Free), 862-298-0702 (International). Please direct the operator to be connected to the Sensus Healthcare conference call.
NEW YORK, NY / ACCESSWIRE / March 16, 2020 / Stratus Properties, Inc. (NASDAQ:STRS) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 16, 2020 at ...
Sensus Healthcare, Inc. (SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, February 13, 2020 at 4:30 p.m. Eastern time to discuss the financial results for the fourth quarter and year ended December 31, 2019. To access the conference call, the dial-in numbers are 888-567-1603 (U.S. and Canada Toll Free), 862-298-0702 (International). Please direct the operator to be connected to the Sensus Healthcare conference call.
New corporate structure positions company for 2020 financial goals BOCA RATON, Fla., Jan. 06, 2020 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company.
JOE SARDANO Age: 67 Birthplace: Montreal Residence: Delray Beach Current position: President, chairman and CEO, Sensus Healthcare Previous positions: Chief commercial officer, Xoft; managing partner and health care consultant, Molecular Imaging Ventures; VP, Siemens Medical Systems; senior VP of global sales and marketing, CTI Molecular Imaging and Pet Net Pharmaceuticals; Americas sales manager of functional imaging at GE Medical Systems; VP of sales and marketing, Eliscint; region sales manager, Toshiba America Medical Systems Education: B.A., Concordia University in Montreal; business certificates from School of Management, McGill University Joe Sardano likes to be in the presence of winners. The walls and tables in his office are covered with signed sports memorabilia from professional athletes he befriended over the years.
Last week saw the newest annual earnings release from Sensus Healthcare, Inc. (NASDAQ:SRTS), an important milestone in...
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, today announced that results from a retrospective study of non-melanoma skin cancer (NMSC) patients treated with superficial radiation therapy (SRT) were published in the February 2020 issue of Journal of Drugs in Dermatology. The study showed a non-recurrence rate of 98.9% after 85 months in 516 patients with a total of 776 NMSC lesions treated with SRT. Patients were treated with the SRT-100™ system marketed by Sensus Healthcare at four clinical sites prior to January 2015.
Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 06, 2019 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in.
Q3 2019 Sensus Healthcare Inc Earnings Call